Date the warrants or rights are exercisable, in CCYY-MM-DD format.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(3))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Basis of Presentation (Details Narrative) - USD ($)										1 Months Ended				2 Months Ended	7 Months Ended	10 Months Ended	12 Months Ended		13 Months Ended	215 Months Ended
Basis of Presentation (Details Narrative) - USD ($)	May 16, 2016	Mar. 25, 2016	Dec. 11, 2015	Nov. 23, 2015	Nov. 11, 2015	Sep. 02, 2015	Aug. 15, 2015	May 05, 2015	Aug. 14, 2014	Dec. 31, 2015	Nov. 30, 2015	May 14, 2015	Jan. 31, 2015	May 31, 2016	Sep. 30, 2015	Mar. 31, 2016	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2015	Mar. 31, 2016	May 12, 2015	Mar. 31, 2014
Description of reverse stock split ratio									1-for-20
Accumulated deficit																$ (131,743,200)	$ (131,743,200)	$ (84,522,700)	$ (84,522,700)	$ (131,743,200)
Cash proceeds from issuance and sale of notes																				34,500,000
Cash proceeds from government research grant awards, strategic collaboration payments and other revenues																				16,400,000
Cash proceeds from issuance of equity securities																				$ 29,100,000
Aggregate face amount																		$ 1,302,600	1,302,600
Extinguishment of debt, amount															$ 17,200,000
Subsequent Event [Member]
Cash proceeds from issuance of equity securities	$ 8,700,000
Number of shares issued	2,352,942
2014 Unit Warrants [Member]
Number of shares issued												24,250						282,850
Warrant [Member]
Number of shares issued		230,000	37,500	7,500	1,123,533	650,000					15,750		381,000
Warrant exercisable date					Mar. 19, 2019
Warrant exercise price (in dollars per share)						$ 9.25
Warrant term						5 years
Warrant [Member] \| Subsequent Event [Member]
Number of shares issued	2,705,883
Warrant exercise price (in dollars per share)	$ 5.30
Warrant term	5 years
10% Convertible Promissory Note (2014 Unit Notes) [Member]
Aggregate face amount																		$ 4,066,900	4,066,900
Promissory Notes And Payables [Member] \| Series B Preferred Stock [Member]
Number of shares issued upon debt conversion															2,618,917
Description of lender names															Cato Research Ltd., Cato Holding Company, Morrison & Foerster LLP (Note A and Note B), McCarthy Tetrault, Burr Pilger & Mayer, University Health Network (Toronto), the Icahn School of Medicine at Mount Sinai, National Jewish Health and others.
Accredited Investors [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Series B Preferred Stock [Member]
Number of shares issued upon debt conversion								265,699
Platinum Long Term Growth VII, LLC [Member]
Cash proceeds from issuance and sale of notes							$ 3,000,000
Platinum Long Term Growth VII, LLC [Member] \| Series B Preferred Stock [Member]
Cash proceeds from issuance and sale of notes																$ 1,650,000
Number of shares issued							458,571			235,714
Platinum Long Term Growth VII, LLC [Member] \| Warrant [Member]
Warrant exercise price (in dollars per share)																					$ 7.00
Private Placement [Member] \| Series B Preferred Stock [Member]
Cash proceeds from issuance and sale of notes																	$ 5,025,800
Number of shares issued																717,978
Private Placement [Member] \| Accredited Investors [Member]
Aggregate face amount																		3,113,500	$ 3,113,500			$ 3,113,500
Private Placement [Member] \| Accredited Investors [Member] \| Series B Preferred Stock [Member]
Cash proceeds from issuance and sale of notes																$ 5,025,800
Private Placement [Member] \| Accredited Investors [Member] \| Series B Preferred Stock [Member] \| Subsequent Event [Member]
Cash proceeds from issuance of equity securities														$ 278,000
Number of shares issued														39,714
Private Placement [Member] \| Accredited Investors [Member] \| Warrant [Member] \| Subsequent Event [Member]
Number of shares issued														39,714
Warrant exercise price (in dollars per share)														$ 7.00
Warrant term														5 years
Private Placement [Member] \| Platinum Long Term Growth VII, LLC [Member] \| 2014 Unit Restricted Stock [Member]
Number of shares issued																			125,000
Private Placement [Member] \| Platinum Long Term Growth VII, LLC [Member] \| 2014 Unit Warrants [Member]
Number of shares issued																			125,000
Private Placement [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Series B Preferred Stock [Member]
Cash proceeds from issuance and sale of notes																$ 2,650,000
Cash proceeds from issuance of equity securities																	$ 5,025,800
Number of shares issued																	717,976
Private Placement [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Warrant [Member]
Number of shares issued																	717,976
Warrant term																	5 years
Private Placement [Member] \| Platinum Long Term Growth VII, LLC [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member]
Aggregate face amount																		$ 1,250,000	$ 1,250,000
Securities Purchase Agreements [Member] \| Accredited Investors [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member]
Cash proceeds from issuance and sale of notes												$ 280,000
Aggregate face amount												$ 280,000
Debt instrument maturity date range start												Apr. 30, 2015
Debt instrument maturity date range end												May 15, 2015
Securities Purchase Agreements [Member] \| Accredited Investors [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member] \| 2014 Unit Restricted Stock [Member]
Number of shares issued												33,000
Securities Purchase Agreements [Member] \| Accredited Investors [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member] \| 2014 Unit Warrants [Member]
Number of shares issued												24,250
Warrant exercisable date												Dec. 31, 2016
Warrant exercise price (in dollars per share)												$ 10.00
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Warrant [Member]
Number of shares issued																	833,020
Securities Purchase Agreements [Member] \| Private Placement [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member]
Cash proceeds from issuance and sale of notes																			50,000
Description of conversion terms																	Entitling the 2014 Unit Note holders at the time of conversion to the 25% Qualified Financing conversion premium under the terms of the 2014 Unit Notes.
Securities Purchase Agreements [Member] \| Private Placement [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member] \| Series B Preferred Stock [Member]
Number of shares issued																	833,020
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Accredited Investors And Institutions [Member]
Cash proceeds from issuance and sale of notes												$ 280,000							$ 3,100,000
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Accredited Investors And Institutions [Member] \| 2014 Unit Restricted Stock [Member]
Number of shares issued																			282,850
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Accredited Investors And Institutions [Member] \| 2014 Unit Warrants [Member]
Number of shares issued																			282,850
Warrant exercisable date																			Dec. 31, 2016
Warrant exercise price (in dollars per share)																		$ 10.00	$ 10.00
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Accredited Investors And Institutions [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member]
Aggregate face amount																		$ 3,100,000	$ 3,100,000
Debt instrument maturity date range start																			Mar. 31, 2015
Debt instrument maturity date range end																			Apr. 30, 2015
Description of conversion terms																			Automatically convertible into securities we might issue upon the consummation of a Qualified Financing.
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Accredited Investors [Member] \| 2014 Unit Restricted Stock [Member]
Number of shares issued												33,000
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Accredited Investors [Member] \| 2014 Unit Warrants [Member]
Number of shares issued												24,250
Warrant exercisable date												Dec. 31, 2016
Warrant exercise price (in dollars per share)												$ 10.00
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Accredited Investors [Member] \| 10% Convertible Promissory Note (2014 Unit Notes) [Member]
Aggregate face amount												$ 280,000
Debt instrument maturity date range start												Apr. 30, 2015
Debt instrument maturity date range end												May 15, 2015
Description of conversion terms												(i) an equity or equity-based public financing registered with the SEC, or (ii) an equity or equity-based private placement, or series of private placements, not registered with the SEC, in either case resulting in gross cash proceeds to us of at least $10.0 million prior to Maturity (a Qualified Financing), the Outstanding Balance of the 2014 Unit Notes would automatically convert into securities substantially similar to those sold in the Qualified Financing, based on the following formula: (the Outstanding Balance as of the closing of the Qualified Financing) x 1.25 / (the per security price of the securities sold in the Qualified Financing).
Securities Purchase Agreements [Member] \| Private Placement [Member] \| Platinum Long Term Growth VII, LLC [Member] \| Series B Preferred Stock [Member]
Number of shares issued								142,857